Literature DB >> 8637456

Effect of CL316,243, a highly specific beta3-adrenoceptor agonist, on sympathetic nervous system activity in mice.

T Yoshida1, T Umekawa, N Sakane, K Yoshimoto, M Kondo.   

Abstract

To examine whether long-term administration of a beta3-adrenoceptor agonist influences sympathetic nervous system (SNS) activity, norepinephrine (NE) turnover, a reliable indicator of SNS activity, in the interscapular brown adipose tissue (IBAT), the heart, and the spleen, as well as urinary excretion of NE, were measured using mice treated with CL316,243 (CL), a highly specific beta3-adrenoceptor agonist, at a dose that stimulated thermogenesis and reduced body weight. CL significantly decreased NE turnover in the IBAT, heart, and spleen and decreased urinary excretion of NE without affecting food intake over 1 to 4 weeks of treatment. These findings show that long-term administration of the beta3-adrenoceptor agonist decreases SNS activity and urinary excretion of NE.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8637456     DOI: 10.1016/s0026-0495(96)90147-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  4 in total

1.  Cold tolerance, cold-induced hyperphagia, and nonshivering thermogenesis are normal in α₁-AMPK-/- mice.

Authors:  Jake D Bauwens; Eric G Schmuck; Christopher R Lindholm; Rebecca L Ertel; Jacob D Mulligan; Ian Hovis; Benoit Viollet; Kurt W Saupe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-05-18       Impact factor: 3.619

2.  Comparative effects of oleoyl-estrone and a specific beta3-adrenergic agonist (CL316, 243) on the expression of genes involved in energy metabolism of rat white adipose tissue.

Authors:  Raquel Ferrer-Lorente; Cristina Cabot; José-Antonio Fernández-López; Marià Alemany
Journal:  Nutr Metab (Lond)       Date:  2010-02-25       Impact factor: 4.169

3.  mTORC1 is Required for Brown Adipose Tissue Recruitment and Metabolic Adaptation to Cold.

Authors:  Sébastien M Labbé; Mathilde Mouchiroud; Alexandre Caron; Blandine Secco; Elizaveta Freinkman; Guillaume Lamoureux; Yves Gélinas; Roger Lecomte; Yohan Bossé; Patricia Chimin; William T Festuccia; Denis Richard; Mathieu Laplante
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

4.  FoxO1 suppresses Fgf21 during hepatic insulin resistance to impair peripheral glucose utilization and acute cold tolerance.

Authors:  Oliver Stöhr; Rongya Tao; Ji Miao; Kyle D Copps; Morris F White
Journal:  Cell Rep       Date:  2021-03-23       Impact factor: 9.423

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.